Form 4: Amedisys Director Bruce D. Perkins Acquires 1,690 Restricted Stock Units

Director Bruce D. Perkins acquired 1,690 restricted stock units in Amedisys Inc., vesting in May 2026.

Summary

• Bruce D. Perkins, a director at Amedisys Inc., acquired 1,690 time-based Restricted Stock Units (RSUs) on May 3, 2025.
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2026, contingent upon Perkins' continued service as a non-employee member of the Issuer's Board of Directors.
• Following the transaction, Perkins beneficially owns 24,097 shares of Amedisys common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally viewed as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent upon Perkins' continued service, aligning his interests with the long-term success of Amedisys.

Industry Context

Acquisitions of company stock by directors are common and are often seen as a positive sign, indicating the director's belief in the company's future prospects. This is a routine disclosure related to insider transactions.

Stakeholder Impact

• The acquisition of RSUs by a director can have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Amedisys, Director, Bruce Perkins, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, AMED